Citigroup Lowers Herbalife (NYSE:HLF) Price Target to $13.00

Herbalife (NYSE:HLF) had its price target decreased by Citigroup from $16.00 to $13.00 in a research report issued on Friday, Benzinga reports. The firm presently has a “buy” rating on the stock. Citigroup’s price objective suggests a potential upside of 93.16% from the company’s previous close.

Other research analysts have also issued reports about the stock. DA Davidson boosted their price target on shares of Herbalife from $9.50 to $13.00 and gave the stock a “neutral” rating in a research note on Thursday, August 1st. StockNews.com lowered shares of Herbalife from a “buy” rating to a “hold” rating in a research note on Tuesday. Finally, B. Riley boosted their price target on shares of Herbalife from $16.00 to $17.00 and gave the stock a “buy” rating in a research note on Thursday, August 1st. One analyst has rated the stock with a sell rating, four have given a hold rating and two have assigned a buy rating to the stock. Based on data from MarketBeat.com, Herbalife has an average rating of “Hold” and an average target price of $12.50.

Herbalife Stock Performance

NYSE HLF traded down $0.18 during trading on Friday, reaching $6.73. The company’s stock had a trading volume of 1,045,928 shares, compared to its average volume of 2,060,436. Herbalife has a twelve month low of $6.59 and a twelve month high of $15.66. The business’s fifty day moving average price is $7.46 and its 200-day moving average price is $9.34. The firm has a market cap of $672.78 million, a price-to-earnings ratio of 4.91, a P/E/G ratio of 0.27 and a beta of 1.19.

Herbalife (NYSE:HLF) last issued its quarterly earnings results on Wednesday, July 31st. The company reported $0.54 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.43 by $0.11. Herbalife had a net margin of 1.63% and a negative return on equity of 18.69%. The business had revenue of $1.28 billion for the quarter, compared to analyst estimates of $1.33 billion. During the same period in the previous year, the business posted $0.74 earnings per share. The business’s revenue was down 2.5% compared to the same quarter last year. As a group, sell-side analysts forecast that Herbalife will post 1.34 EPS for the current fiscal year.

Insider Buying and Selling

In other Herbalife news, Director Juan Miguel Mendoza purchased 10,000 shares of Herbalife stock in a transaction on Monday, September 9th. The shares were bought at an average price of $7.11 per share, with a total value of $71,100.00. Following the completion of the acquisition, the director now directly owns 120,000 shares of the company’s stock, valued at approximately $853,200. This trade represents a 0.00 % increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. 0.94% of the stock is owned by insiders.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently made changes to their positions in the company. Russell Investments Group Ltd. boosted its stake in shares of Herbalife by 5,249.2% in the first quarter. Russell Investments Group Ltd. now owns 138,599 shares of the company’s stock valued at $1,390,000 after purchasing an additional 136,008 shares during the period. Capstone Investment Advisors LLC purchased a new position in shares of Herbalife in the first quarter valued at $1,397,000. Price T Rowe Associates Inc. MD boosted its stake in shares of Herbalife by 4.6% in the first quarter. Price T Rowe Associates Inc. MD now owns 82,287 shares of the company’s stock valued at $827,000 after purchasing an additional 3,647 shares during the period. Baupost Group LLC MA boosted its stake in shares of Herbalife by 128.3% in the second quarter. Baupost Group LLC MA now owns 5,124,526 shares of the company’s stock valued at $53,244,000 after purchasing an additional 2,879,603 shares during the period. Finally, Marshall Wace LLP boosted its stake in shares of Herbalife by 2,053.6% in the second quarter. Marshall Wace LLP now owns 1,977,155 shares of the company’s stock valued at $20,543,000 after purchasing an additional 1,885,346 shares during the period.

Herbalife Company Profile

Herbalife Ltd. provides health and wellness products in North America, Mexico, South and Central America, Europe, the Middle East, Africa, China, and the Asia Pacific. It offers products in the areas of weight management; targeted nutrition; energy, sports, and fitness; outer nutrition; and literature and promotional items.